In this week's edition...
 
— Advocates Request Changes to the VA National Formulary Act of 2025. View the letter here.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— DOJ Attacks the Americans with Disabilities Act and Section 504 Integration Mandate, Impact on People with Disabilities, Rare Diseases and Older Adults Massive. Learn more HERE and HERE.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— DOJ Attacks the Americans with Disabilities Act and Section 504 Integration Mandate, Impact on People with Disabilities, Rare Diseases and Older Adults Massive. Learn more HERE and HERE.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— Accessible Healthcare for People with Disabilities: An Implementation Guide for Healthcare Organizations. View and share the resource HERE.
— Liver Disease Set of Patient-Centered Outcome Measures. To learn more about this project, please visit the website here. You can share the patient survey here.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

In this week's edition...
 
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— States Attack Section 504 of the Rehabilitation Act and the Integration Mandate, Impact on People with Disabilities, Rare Diseases and Older Adults Massive. View the Arc of Indiana press release HERE. Learn more HERE about how state advocates can push back.
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— Accessible Healthcare for People with Disabilities: An Implementation Guide for Healthcare Organizations. View and share the resource HERE.
— Liver Disease Set of Patient-Centered Outcome Measures. To learn more about this project, please visit the website here. You can share the patient survey here.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

In this week's edition...
 
— House Appropriations Bill Seeks to Rescind PCORI Funds. View section 530 here. Learn more about PCORI here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— States Attack Section 504 of the Rehabilitation Act and the Integration Mandate, Impact on People with Disabilities, Rare Diseases and Older Adults Massive. View the Arc of Indiana press release HERE. Learn more HERE about how state advocates can push back.
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— Accessible Healthcare for People with Disabilities: An Implementation Guide for Healthcare Organizations. View and share the resource HERE.
— Liver Disease Set of Patient-Centered Outcome Measures. To learn more about this project, please visit the website here. You can share the patient survey here.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.